Entry Detail



General Information

Database ID:exR0080646
RNA Name:RPS17
RNA Type:mRNA
Chromosome:chr15
Starnd:-
Coordinate:
Start Site(bp):82536750End Site(bp):82540459
External Links:ENSG00000182774



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABCA3
chr16
2275881
2340746
-
AC004832.3
chr22
30409255
30428990
+
AC007192.1
chr19
18153158
18178117
+
AC011005.1
chr7
129126518
129130793
+
AC011462.1
chr19
41350853
41425001
+
AC020909.1
chr19
50415799
50428409
+
AC024592.3
chr19
5866171
5903787
-
AC025165.3
chr12
57772660
57797554
+
AC245033.1
chr15
82536788
82573194
-
ACAD9
chr3
128879596
128916067
+
ACO2
chr22
41469117
41528989
+
ACTB
chr7
5527148
5563784
-
ACTC1
chr15
34790230
34795549
-
ACTN1
chr14
68874143
68979440
-
ACTN4
chr19
38647649
38731589
+
ACTR1A
chr10
102461881
102502712
-
ACTR3
chr2
113890063
113962596
+
ADO
chr10
62804720
62808479
+
AHCYL1
chr1
109984765
110023742
+
AK3
chr9
4709556
4742043
-
AL110118.2
chr14
93184973
93218586
+
AL121845.3
chr20
63708864
63739103
+
AL132780.3
chr14
22946270
22982258
-
AL133352.1
chr10
100505628
100529881
-
AL590764.2
chrX
71103987
71111575
-
AL603832.3
chr1
112702614
112711433
-
ALDOA
chr16
30064164
30070457
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-155-5p
chr21
25573983
25574006
+
hsa-miR-155-3p
chr21
25574022
25574043
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC016876.2
chr17
7581964
7584086
-
AC025181.2
chr5
32174471
32175272
+
AC026304.1
chr3
143000907
143001467
-
AC026362.1
chr12
122975320
122982907
+
AC087482.1
chr15
66984103
67065268
-
AC091564.7
chr11
6610883
6616594
-
AC114763.1
chr2
138418284
138501698
-
AC124312.5
chr15
25091786
25107469
-
AC132217.1
chr11
2129121
2129964
-
AC245033.4
chr15
82533175
82540008
-
AD000090.1
chr19
35557956
35581954
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA